Abstract
Introduction
With the aging of the human population around the world, the need for the management of diseases of the elderly, such as rheumatoid arthritis and other joint problems, has emerged. Also the majority of diseases can cause arthropathy, such as spondylarthropathy, Lyme disease, Behcet's disease, persistent synovial effusion, hemophilic arthritis, calcium pyrophosphate dihydrate (CPPD) arthritis, pigmented villonodular synovitis (PVNS), persistent effusion after joint prosthesis, undifferentiated arthritis, etc., leading to pain, inflammation and also immobility of patients [1] .
Radiosynovectomy (RSV) has been proposed as a potent palliative therapy around the world for the last 2 decades [1] , and several radiopharmaceuticals have been developed for RSV, including 166 Ho-macroaggregates [2] and Ho-166 phytate complex [3] .
Many beta-emitters such as 153 Sm, 177 Lu and 166 Ho can be produced in reasonable amounts using (n, gamma) reactions, and holmium-166 (E β − max=1.84 MeV, T 1/2 = 26.8 h) is one of the most interesting radionuclides for the development of therapeutic radiopharmaceuticals such as 166 Ho-DOTMP for bone palliation therapy [4] , 166 Ho-DTPA in endovascular beta irradiation therapy [5] , 166 Hooxine-lipiodol in liver cancer therapy [6] and also 166 Ho patches in the treatment of skin cancers [7] .
In this research, 166 Ho-phytate complex production is described in detail, followed by the determination of complex radiochemical purity, stability and biodistribution (after intraarticular injection) in wild-type male rats.
Materials and Methods
Production of 166 Ho was performed at the Tehran Research Reactor (TRR) using a nat Ho (n, gamma) 166 Ho nuclear reaction. Natural holmium nitrate with purity >99.99% was obtained from Aldrich Co. Phytate complex was prepared using a commercial phytate kit (Kavoshyar Co., Tehran, Iran, stannous chloride free). Chromatography paper, Whatman no. 1, was obtained from Whatman (Maidstone, UK). Radiochromatography was performed by using a bioscan AR-2000 radio TLC scanner instrument (Bioscan, Washington, DC). A high-purity germanium (HPGe) detector coupled with a Canberra™ (model GC1020-7500SL) multichannel analyzer and a dose calibrator ISOMED 1010 (Dresden, Germany) were used for counting distributed activity in rat organs. All other chemical reagents were purchased from Merck (Darmstadt, Germany). Calculations were based on the 81-keV peak for 166 Ho. All values were expressed as mean ± standard deviation (mean ± SD), and the data were compared using Student's t-test. Statistical significance was defined as P<0.05. Animal studies were performed in accordance with the UK Biological Council's Guidelines on the Use of Living Animals in Scientific Investigations, 2nd edition. All of the rats were purchased from Pasteur Institute of Iran, weighed 180-220 g (n=5) and were kept at a routine day/night light program; they were fed common rodent diet pellets. 3 and diluted to the appropriate volume with ultra-pure water to produce a stock solution. The mixture was filtered through a 0.22-μm biological filter and sent for use in the radiolableing step. The radionuclidic purity of the solution was tested for the presence of other radionuclides using beta spectroscopy as well as HPGe spectroscopy for the detection of various interfering beta and gamma emitting radionuclides. The radiochemical purity of the 166 Ho]holmium chloride acidic solution prepared as described above was transferred to a sterile borosilicate vial, and the mixture was evaporated using a flow of N 2 gas and slight warming (50°C) for 5 min. Sterile normal saline solution (1 ml) was added to a commercial phytate kit (containing 10 mg phytic acid, no SnCl 2 ), followed by vigorous shaking for 30 s. The phytate mixture was then added in one portion to the activitycontaining vial followed by stirring. The radiolabeling of the kit was checked by ITLC every 10 min. After completion of the labeling, the mixture was filter-sterilized using a 0.22-micron membrane.
Quality Control
For measuring radiochemical purity and radiolabeling yield, a 1-μl sample of the [
166 Ho]holmium phytate complex was spotted on a chromatography paper (Whatman no. 1) and developed in a mixture of methanol/water/acetic acid (4:4:2) as the mobile phase.
Stability Testing of the Radiolabeled Compound in Final Formulation
Stability of 166 Ho-phytate in final preparation was determined by storing the final solution at 4, 25 and 37°C for 2 days and performing frequent ITLC analysis to determine radiochemical purity. Also after subsequent 166 Ho-labeling of the 2 month-stored kit, both labeling efficiency and radiochemical purity were determined. Ho] holmium phytate in the intraarticular cavity, their isotonic solutions were carefully administered to wild-type rats. A volume (100 μl) of final radiolabeled solution containing 120-150 μCi radioactivity was injected intraarticularly to rats. The animals were killed at exact time intervals (2, 24 and 48 h). The specific activity of different organs was calculated as percentage of area under the curve of 80 keV peak per gram using an HPGe detector.
Results and Discussion
Production and Quality Control of 166 Ho
The radionuclide was prepared in a research reactor according to regular methods with a range of specific activity of 3-5 MBq/mg for radiolabeling use. After counting the samples on an HPGe detector for 5 h, two major photons (5.4% of 0.081 MeV and 0.9% of 1.38 MeV) were observed ( Figs. 1 and 2 ). The radioisotope was dissolved in acidic media as a starting sample and was further diluted and evaporated for obtaining the desired pH and volume followed by sterile filtration. The radiochemical purity of the 166 Ho solution was checked in two solvent systems; in 10 mM DTPA, free Ho 3+ cation is complexed to a more lipophilic [ 166 Ho]-DTPA form and migrates to higher R f , whereas a small radioactive fraction remains at the origin, which could be related to other free Ho ionic species, such as HoCl 4 − , etc., and/or colloids.
On the other hand, a 10% ammonium acetate:methanol mixture (1:1) was also used for the determination of radiochemical purity. The fast-eluting species was possibly the ionic 166 Ho cations other than Ho 3+ , and the remaining fraction at Rf=0 was a possible mixture of Ho 3+ and/or colloids. Due to existence of 1% impurity in both cases, the existence of colloids is unlikely (Fig. 3) Ho]holmium chloride activity (30 mCi). The phytate that had a molecular weight of 400 kDa was used to investigate of effect of phytate concentration on labeling yield at pH=3.5.
Labeling yield increased with increasing phytate concentration and reached above 98% when the concentration reached 35 mg/3 ml. The highest labeling yield was achieved at pH=2.8-3.2, while it decreased beyond this range. A labeling yield of 99% was achieved after 30 min. The effect of absence and presence of ascorbic acid (at various concentrations) as a complex stabilizer was also studied. ITLC using a mixture of methanol, water and acetic acid showed that the complex is mostly prepared in 30 min with 99% radiochemical purity; the remaining 1% is possibly attributed to other Ho ionic species that cannot react with phytate (Fig. 4) .
Based on the obtained results, the optimal procedure for the preparation of [
166 Ho]holmium phytate complex with a high labeling yield is as follows: 35 mg of phytate (MW= 400 kDa) was dissolved in 3.5 ml of 1% acetic acid aqueous solution. The acidity of the obtained solution was adjusted to pH=3 by the addition of 0.5 M NaOH solution and followed by the addition of [
166 Ho]holmium chloride solution. Finally, the total volume was adjusted to 4 ml by the addition of deionized water.
Stability Studies of [ 166 Ho]holmium Phytate Complex
The stability of prepared [ 166 Ho]holmium phytate complex was checked up to 48 h after preparation. The complex was stable in acidic media (pH=3.5), and its radiochemical purity was above 99% even 48 h after preparation. Also the stability of the complex was determined at 4°, 25 and 37°C for 2 days, and the data were almost consistent with the final solution stability.
Biodistribution Studies for Free Ho 3+ Cation in Rats
The tissue uptakes were calculated as the percent of area under the curve of the related photo peak per gram of tissue (% ID/g) (Fig. 5) . The biodistribution of Ho 3+ cation was determined in wild-type animals for 2-48 h post-injection. The liver uptake of the cation is comparable to many other radiolanthanide mimicking calcium cation accumulation; about 3.5% of the cation accumulates in the liver. The transferin metal uptake and final liver delivery look like the possible route of accumulation. The blood content is low at all time intervals, and this shows the rapid removal of activity in the Hophytate solution (right) on Whatman no. 1 paper using a methanol: water: acetic acid (4:4:2) mixture circulation. Brain, muscle and also skin did not demonstrate significant uptake. A 0.5-1% bone uptake was observed for the cation, which remains almost constant up to 24 h. Spleen also showed significant uptake possibly related to reticuluendothelial uptake. Figure 6 presents the distribution of the injected dose in the rat organs at various time intervals after intratumoral injection of 60 μCi/100 μl of [ 166 Ho]holmium phytate complex as percentage of injected dose. In case of any leak from the joint, the complex would accumulate in the reticuluendothelial (RE) system because of the high molecular weight of the complex, unless the complex dissociated at serum pH and Ho 3+ cation was formed. Almost no detectable amounts of activity were observed in the spleen and lung, which are two important RE organs, showing no complex leak occurred. Very negligible liver and kidney uptakes were observed, which was possibly caused by 166 Ho cation release from the injected joint and not the radiolabeled complex uptake. Figure 7 demonstrates the biodistribution of the compound among the tissues excluding the injected knee data in order to better understand the biodistribution of the leaks from the knee.
The distribution of the radioactivity among tissues after removing knee joint accumulation data demonstrated a typical Ho 3+ cation biodistribution among the tissues. It is believed that free Ho cation is the only radiochemical species escaping from the knee joint, and no 166 Ho-phytate complex was found in circulation.
Conclusion

The [
166 Ho]holmium phytate complex was prepared with a high radiochemical yield (>99 %) in the optimized condition: 35 mg/3 ml of phytate concentration in diluted acetic acid solution (pH=3). The prepared complex was stable in the final solution at room temperature, 37°C and presence of human serum, and can be used even 24 h after preparation. Intraarticular injection of [
166 Ho]holmium phytate complex to male wild-type rats and investigation of leakage of activity in the body showed that most of injected dose remained in the injection site 144 h after injection.
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